OBJECTIVE: To systematically review the clinical efficacy and safety of Fuke Qianjin tablets（ capsule）combined with clindamycin in the treatment of pelvic inflammatory. METHODS: Randomized controlled trials in Chinese and English on Fuke Qianjin tablets（ capsule） combined with clindamycin in the treatment of pelvic inflammatory[the research group was given Fuke Qianjin tablets（ capsule） combined with clindamycin

while the control group was given clindamycin alone]were retrieved from CNKI

Wanfang database VIP database and Pub Med from basebuilding to Nov. 2020

after the literature screening according to the inclusion and exclusion criteria

the data was extracted and evaluated or publication risk bias

and the Rev Man 5. 3 was adopted to conduct a Meta-analysis on the included literature. RESULTS: Totally 12 studies were involved

including 1 426 patients

of which 715 patients were in the research group and 711 patients were in the control group; 7 studies had mentioned adverse drug reactions. Results of Meta-analysis indicated that the effective rate（ OR = 3. 31

95% CI = 2. 38-4. 59

Z = 7. 15

P < 0. 000 01）

incidence of adverse drug reactions（ OR = 0. 43

95% CI = 0. 25-0. 74

Z = 3. 04

P = 0. 002）

improvement of hypogastralgia（ MD=-0. 73

95% CI =-0. 84--0. 62

Z = 12. 80

P < 0. 000 01） and improvement of leucorrhea amount（ MD =-0. 80

95% CI =-0. 98--0. 61

Z = 8. 38

P < 0. 000 01） of research group were significantly better than those of the control group

with statistically significant differences. CONCLUSIONS: The combination of Fuke Qianjin tablets（ capsule） and clindamycin has good effectiveness and high safety in the treatment of pelvic inflammatory.